Fulminant myocarditis parvovirus B19 related in a young woman.
Rita PescePierPaolo TaffarelloStefania RizzoCristina BassoLuisa CacciavillaniAlvise Del MonteLuciano BabuinGino GerosaTomaso Bottio Jean Christian RousselPublished in: Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs (2021)
We present the case of a 18-year-old female with fulminant lymphocytic myocarditis caused by Parvovirus B19 (PVB19), successfully treated using temporary LVAD. In the literature there is no consensus on the surgical strategy. While some surgeons prefer to use a single device supporting only the LV, others prefer to start immediately with a biventricular supporting. At pre-procedural ultrasound evaluation, her anatomical features were not suitable for a percutaneous device such as the Impella. Thus, a temporary paracorporeal continuous flow LVAD was inserted. The heart recovery allowed LVAD removal 9 days after the implant.
Keyphrases
- left ventricular assist device
- ultrasound guided
- systematic review
- magnetic resonance imaging
- heart failure
- liver failure
- minimally invasive
- quality improvement
- atrial fibrillation
- clinical practice
- case report
- middle aged
- extracorporeal membrane oxygenation
- computed tomography
- radiofrequency ablation
- contrast enhanced ultrasound